Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons
- 28 January 2005
- journal article
- Published by Elsevier BV in Experimental Neurology
- Vol. 192 (1), 226-234
- https://doi.org/10.1016/j.expneurol.2004.11.030
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Inhibition of brain‐derived neurotrophic factor and glial cell line‐derived neurotrophic factor expression reduces dopaminergic sprouting in the injured striatumEuropean Journal of Neuroscience, 2000
- Activated Macrophages and Microglia Induce Dopaminergic Sprouting in the Injured Striatum and Express Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic FactorJournal of Neuroscience, 1999
- Neurotrophin trafficking by anterograde transportTrends in Neurosciences, 1998
- Effects of BDNF and NT‐4/5 on Striatonigral Neuropeptides or Nigral GABA Neurons In VivoEuropean Journal of Neuroscience, 1996
- The Neurotrophins NT-4/5 and BDNF Augment Serotonin, Dopamine, and GABAergic Systems during Behaviorally Effective Infusions to the Substantia NigraExperimental Neurology, 1994
- Design and application of antisense oligonucleotides in cell culture,in vivo, and as therapeutic agentsCellular and Molecular Neurobiology, 1994
- Efficacy of Brain‐Derived Neurotrophic Factor and Neurotrophin‐3 on Neurochemical and Behavioral Deficits Associated with Partial Nigrostriatal Dopamine LesionsJournal of Neurochemistry, 1994
- Partial lesion of the substantia nigra: relation between extent of lesion and rotational behaviorBrain Research, 1991
- Biochemistry of Parkinson's disease 28 years later: A critical reviewMovement Disorders, 1989
- Compensatory bilateral changes in dopamine turnover after striatal kainate lesionNature, 1980